Is Nebzmart GF (glycopyrronium, formoterol, budesonide) a steroid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Nebzmart GF a Steroid?

Yes, Nebzmart GF contains a steroid—specifically budesonide, which is an inhaled corticosteroid (ICS).

Composition of Nebzmart GF

Nebzmart GF is a triple-therapy combination inhaler containing three active components 1, 2:

  • Glycopyrronium (also called glycopyrrolate): A long-acting muscarinic antagonist (LAMA)
  • Formoterol fumarate: A long-acting β2-agonist (LABA)
  • Budesonide: An inhaled corticosteroid (ICS)

Understanding Budesonide as a Corticosteroid

Budesonide is definitively a corticosteroid, classified specifically as an inhaled corticosteroid used for anti-inflammatory effects in respiratory disease 3. The drug works by:

  • Reducing airway inflammation
  • Decreasing mucus production
  • Preventing exacerbations in chronic obstructive pulmonary disease (COPD) and asthma

The FDA drug label confirms budesonide's chemical designation as a corticosteroid: "(RS)-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde" with molecular formula C₂₅H₃₄O₆ 3.

Clinical Context

This triple-therapy formulation (budesonide/glycopyrronium/formoterol, or BGF) represents the current standard approach for patients with moderate-to-severe COPD 4. The combination provides:

  • Bronchodilation from both the LAMA (glycopyrronium) and LABA (formoterol)
  • Anti-inflammatory effects from the ICS (budesonide)
  • Reduced exacerbation rates compared to dual therapy 2, 5

Important clinical consideration: While budesonide is a steroid, it is an inhaled corticosteroid with primarily local effects in the airways. The systemic absorption is approximately 6% of the labeled dose 3, making it far safer than oral corticosteroids with significantly fewer systemic side effects. However, patients should still be monitored for potential corticosteroid-related adverse effects, particularly pneumonia risk in COPD patients 4 and HPA axis suppression with prolonged high-dose use 3.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.